The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Differential Roles of Opioid Receptors in Respiration, Respiratory Disease, and Opiate-induced Respiratory Depression
Abstract
Abstract In summary, these findings indicate the importance of designing future experiments that delineate between opioid and nonopioid forms of respiratory disease and dysfunction, and the need to identify means of diagnosing them in order to achieve successful recovery. Apparently there is great diversity between animal species in terms of contributions of endogenous opiods to tonic control of ventilation, and future work should strive to identify which species is most appropriate as a model of human ventilatory control and disease. Certain opioid receptor types appear to be linked to independent respiratory functions. For instance, mu receptors in the brain stem produce strong inhibitory actions on respiratory parameters, inculding RR, Vt, e, and CO2 sensitivity. These effects have been observed in vivo and by electrophysiologic recordings in vitro. Delta receptors may also exert some inhibitory effect on respiration, especially in the NTS. In the CNS, the ventral surfaces of the medulla and pons, especially he NTS and NA, seem to be important sites for opioid-induced inhibition of respiration, whereas the spinal cord probably is not involved in opioid-mediated ventilatory depression. Kappa receptors appear to be devoid of respiratory depressant activity, whereas sigma receptors may stimulate some ventilatory parameters. Morphine and similar pure mu agonists, such as fentanyl and oxymorphine, probably produce their analgesic and respiratory depressant effects through stimulation of mu receptors. Mixed agonists/antagonists that have mu antagonist (or partial agonist) activity plus kappa agonist and/or sigma agonist activity show a ceiling effect for respiratory depression. Future tests need to determine which opioid receptor may be responsible for the ceiling effect. In addition, the effects of mu, delta, kappa, and sigma selective agonists on hypoxic drive should also be determined, as a drug that stimulates hypoxic sensitivity in the face of hypercapnic depression may produce less overall respiratory depression due to counteractive effects. In the future, clinically optimal opiates should have more specificity of action than those available now. This may be achieved by creating drugs selective for single receptors or by creating drugs with desirable combinations of receptor selectivities. The combinations of mixed agonists/antagonists with pure mu agonists currently in use today are promising, as they provide analgesia with reduced respiratory depression. In the early days of opiate research and development, combination drug regimens were thoroughly tested to determine the “ideal ratios” that would retain analgesic properties but not the other undesirable effects such as respiratory depression (196). This approach did not meet with much success at that time, although the recent development of opiates with narrower receptor selectivities may yield better success in combination regimens, with better selectivity of action. Much work is needed to determine the ideal ratios of combinations of such drugs as butorphanol, fentanyl, buprenorphine, etc. Advances in opiate-related anesthesia and management of pain are dependent on determination of the pharmacologic profiles of the individual opioid receptors and on the development of drugs with optimal receptor selectivity and function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of two related pentapeptides from the brain with potent opiate agonist activity
Hughes, J., Smith, T. W., Kosterlitz, H. W., Fothergill, L. A., Morgan, B. A., & Morris, H. R. (1975) · Nature · doi:10.1038/258577a0 · Cited by 3,806
Endogenous opioid peptides: multiple agonists and receptors
Lord, J. A. H., Waterfield, A. A., Hughes, J., & Kosterlitz, H. W. (1977) · Nature · doi:10.1038/267495a0 · Cited by 2,485
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
Pain Relief by Intrathecally Applied Morphine in Man
Wang, J. K., Nauss, L. A., & Thomas, J. E. (1979) · Anesthesiology · doi:10.1097/00000542-197902000-00013 · Cited by 936
Regional Distribution of Opiate Receptor Binding in Monkey and Human Brain
KUHAR, M. J., PERT, C. B., & SNYDER, S. H. (1973) · Nature · doi:10.1038/245447a0 · Cited by 820
Organization of endogenous opiate and nonopiate pain control systems
Watkins, L. R., & Mayer, D. J. (1982) · Science · doi:10.1126/science.6281891 · Cited by 791
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
Mosberg, H. I., Hurst, R., Hruby, V. J., Gee, K., Yamamura, H. I., Galligan, J. J., & Burks, T. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5871 · Cited by 740
Opioid peptide enkephalin: immunohistochemical mapping in rat central nervous system.
Simantov, R., Kuhar, M. J., Uhl, G. R., & Snyder, S. H. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.5.2167 · Cited by 621
TREATMENT OF EXCESSIVE AXILLARY SWEATING
Gibbs, J. R. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91979-5 · Cited by 559
Analogues of β-LPH61–64 posessing selective agonist activity at μ-opiate receptors
Handa, B. K., Lane, A. C., Lord, J. A. H., Morgan, B. A., Rance, M. J., & Smith, C. F. C. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90364-2 · Cited by 506
Cited by
Pathophysiology of Sleep Apnea
Dempsey, J. A., Veasey, S. C., Morgan, B. J., & O'Donnell, C. P. (2010) · Physiological Reviews · doi:10.1152/physrev.00043.2008 · Cited by 2,243
Exploring the opioid system by gene knockout
Kieffer, B. L., & Gavériaux-Ruff, C. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00008-4 · Cited by 620
Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.
Yasuda, K., Raynor, K., Kong, H., Breder, C. D., Takeda, J., Reisine, T., & Bell, G. I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6736 · Cited by 618
Side effects of intrathecal and epidural opioids
Chaney, M. A. (1995) · Canadian Journal of Anaesthesia · doi:10.1007/bf03011037 · Cited by 562
Eckert, D. J., Jordan, A. S., Merchia, P., & Malhotra, A. (2007) · Chest · doi:10.1378/chest.06.2287 · Cited by 559
Metadata
- Authors
- Shook, J. E., Watkins, W. D., & Camporesi, E. M.
- Venue
- American Review of Respiratory Disease
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-10
- Volume
- 142
- Issue
- 4
- Pages
- 895-909
- ISSN
- 0003-0805 (ISSN-L)
- OpenAlex
- W2112970723
- Cited by
- 280
- References
- 39
- FWCI
- 2.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Differential Roles of Opioid Receptors in Respiration, Respiratory Disease, and Opiate-induced Respiratory Depression. https://app.cochat.ai/papers/10.1164/ajrccm/142.4.895
- The paper
- Shook, J. E., Watkins, W. D., & Camporesi, E. M. (1990). Differential Roles of Opioid Receptors in Respiration, Respiratory Disease, and Opiate-induced Respiratory Depression. American Review of Respiratory Disease. https://doi.org/10.1164/ajrccm/142.4.895
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.